MATTHEW W. FOEHR - 10 Jun 2022 Form 4 Insider Report for LIGAND PHARMACEUTICALS INC (LGND)

Signature
By: Charles S. Berkman For: Matthew W. Foehr
Issuer symbol
LGND
Transactions as of
10 Jun 2022
Transactions value $
$0
Form type
4
Filing time
14 Jun 2022, 17:55:29 UTC
Previous filing
13 May 2022
Next filing
30 Sep 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction LGND Common Stock Award $0 +9.14K +5.27% $0.00 182K 10 Jun 2022 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.